Question 1

Does AQR Capital Management own HBIO stock?

Accepted Answer

No. AQR Capital Management exited its HBIO (Harvard Bioscience) position in Q3 2025. Its Q2 2025 13F listed 45,706 shares worth $20,285.

Question 2

How many shares of HBIO does AQR Capital Management own?

Accepted Answer

None since Q3 2025, when AQR Capital Management exited the position. Its Q2 2025 13F listed 45,706 shares worth $20,285.

Question 3

What is AQR Capital Management's HBIO position worth?

Accepted Answer

AQR Capital Management's HBIO position was worth $20,285 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is AQR Capital Management buying or selling HBIO?

Accepted Answer

In Q3 2025, AQR Capital Management exited its entire HBIO position.

Question 5

When did AQR Capital Management first buy HBIO?

Accepted Answer

AQR Capital Management first reported HBIO in its Q2 2021 13F and listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$4.40	0
2025-Q2	Increased	45,706	+100.6%	$20,285	0.0%	$4.40	21
2025-Q1	New	22,780	—	$12,894	0.0%	$5.70	27